Nefi Acosta is an attorney in the Los Angeles office of Munger, Tolles & Olson. His practice focuses on complex civil litigation and data privacy and security. Mr. Acosta has experience litigating in federal and state court, including writing dispositive motions, taking depositions, and managing all aspects of discovery. He also has experience advising public and private companies on compliance with data privacy and security regulations.
Prior to joining the firm, Mr. Acosta clerked for Judge Thelton E. Henderson of the U.S. District Court for the Northern District of California and was an extern for Judge Stephen Reinhardt of the U.S. Court of Appeals for the Ninth Circuit.
Mr. Acosta earned his law degree from UC Irvine School of Law, where he completed more than 200 hours of pro bono work and served as a lead article editor of the UC Irvine Law Review. During law school, he interned for the American Civil Liberties Union of Southern California and Kia Motors America, Inc. Mr. Acosta continues to give back to his community through maintaining an active pro bono practice and serving on the board of directors for the Community Legal Aid SoCal and board of trustees for the Mexican American Bar Foundation. Mr. Acosta was first in his family to graduate from college and received his undergraduate degree in political science with a minor in automotive technology from Utah Valley University.
Mr. Acosta is fluent in Spanish and is a Certified Information Privacy Professional in both U.S. and European regulations (CIPP/US & CIPP/E).
- Co-Author, “What To Remember About Calif.’s Right To Be Forgotten,” Law360, November 2018
- Co-Author, “SEC Warns Corporations about BEC Attacks,” Client Alert, November 2018
- Co-Author, “New SEC Cyber Report Puts Spotlight On Accounting Controls,” Law360, October 2018
- Co-Author, “What Corporate Attorneys Should Know About the California Consumer Privacy Act,” Law360, September 2018
- Co-Author, “The California Consumer Privacy Act: 3 Early Questions,” Law360, July 2018
- Co-Author, “The New Federalism: State Policies Regarding Embryonic Stem Cell Research,” 44 J. L. Med. & Ethics 419 (2016)